During the past decade, Maine Medical Partners Pediatric Specialty Care conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maine Medical Partners Pediatric Specialty Care" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials, followed by "Nicole Hamblett" with 1 trials sponsored, "Rhythm Pharmaceuticals, Inc." with 1 trials sponsored, "Savara Inc." with 1 trials sponsored and "Seattle Children's Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Medical Partners Pediatric Specialty Care" #1 collaborator was "Cystic Fibrosis Foundation" with 2 trials as a collaborator, "CF Therapeutics Development Network Coordinating Center" with 1 trials as a collaborator, "Dartmouth-Hitchcock Medical Center" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "University of Washington" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Maine Medical Partners Pediatric Specialty Care" are "Cystic Fibrosis" (3 trials), "Herpes Simplex" (2 trials), "MRSA" (1 trials) and "Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations" (1 trials). Many other conditions were trialed in "Maine Medical Partners Pediatric Specialty Care" in a lesser frequency.

Most popular intervention types in "Maine Medical Partners Pediatric Specialty Care" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acyclovir" (2 trials), "Placebo" (2 trials), "Continuation of dornase alfa (dnase)" (1 trials), "Continuation of hypertonic saline (HS)" (1 trials) and "Discontinuation of dornase alfa (dnase)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maine Medical Partners Pediatric Specialty Care" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Maine Medical Partners Pediatric Specialty Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Maine Medical Partners Pediatric Specialty Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maine Medical Partners Pediatric Specialty Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".